Upasana Biomedical Research & Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -5.88%
(FY 2022)
- Profit -14.31%
(FY 2022)
- Ebitda 2.55%
(FY 2022)
- Net Worth 2.09%
(FY 2022)
- Total Assets 1.82%
(FY 2022)
About Upasana Biomedical Research & Industries
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhirup Mukherjee, Buddhadev Mukherjee, and Mousumi Mukherjee serve as directors at the Company.
- CIN/LLPIN
U33111WB2016PTC209834
- Company No.
209834
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Upasana Biomedical Research & Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhirup Mukherjee  | Director | 18-Feb-2016 | Current |
| Buddhadev Mukherjee | Director | 18-Jan-2022 | Current |
| Mousumi Mukherjee | Director | 18-Feb-2016 | Current |
Financial Performance of Upasana Biomedical Research & Industries.
Upasana Biomedical Research & Industries Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.88% decrease. The company also saw a substantial fall in profitability, with a 14.31% decrease in profit. The company's net worth moved up by a moderate rise of 2.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Upasana Biomedical Research & Industries?
In 2022, Upasana Biomedical Research & Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kumropotash Games Private LimitedActive 2 years 3 months
Buddhadev Mukherjee and Mousumi Mukherjee are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Upasana Biomedical Research & Industries?
Unlock and access historical data on people associated with Upasana Biomedical Research & Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Upasana Biomedical Research & Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upasana Biomedical Research & Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
